Product
HC-ER
Aliases
20 mg HC-ER, ELN154088, Zohydro ER, Zohydro Extended Release (ER)
5 clinical trials
4 indications
Indication
Liver ImpairmentIndication
HealthyIndication
Postoperative PainIndication
Renal ImpairmentClinical trial
Evaluation of the Effect of Hepatic Impairment on the Pharmacokinetics and Metabolism of Hydrocodone and Its Metabolites Following Administration of Hydrocodone Bitartrate Extended-Release (HC-ER) 20mg CapsulesStatus: Completed, Estimated PCD: 2011-05-01
Clinical trial
Single-center, Open-Label, 3-Period Crossover, Phase 1 Study to Evaluate the Pharmacokinetics of Hydrocodone Bitartrate Extended-Release (HC-ER) Capsules 50 mg When Co-Administered With Alcohol in Healthy Subjects Under Fasted ConditionsStatus: Completed, Estimated PCD: 2009-12-01
Clinical trial
A Pilot Study in Healthy Volunteers to Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release (HC-ER) Capsules, in Both Fed and Fasted StatesStatus: Completed, Estimated PCD: 2002-06-01
Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Active Comparator Study of Hydrocodone Bitartrate Extended Release (HC-ER) in Adults Following Bunionectomy SurgeryStatus: Completed, Estimated PCD: 2003-02-01
Clinical trial
Evaluation of the Effect of Renal Impairment on the Pharmacokinetics and Metabolism of Hydrocodone and Its Metabolites Following Administration of Hydrocodone Bitartrate Extended-Release (HC-ER) 20 mg CapsulesStatus: Completed, Estimated PCD: 2011-05-01